by Allison Sit Dermatology Advisor, Dermatology News, Healio, Medriva and Medscape all covered a Journal of Drugs in Dermatology study about the long-term safety and effectiveness of topical clascoterone for…
In our atlas image series we showcase side-by-side images of some of the most commonly seen dermatology conditions in an array of skin tones and briefly highlight nuances in clinical…
Next Steps in Derm and the Journal of Drugs in Dermatology, in partnership with the Dermatology Education Foundation (DEF) and Physicians Resources, interviewed Dr. Adam Friedman, professor and chair of dermatology at GW School…
Next Steps in Derm and the Journal of Drugs in Dermatology, in partnership with the Dermatology Education Foundation (DEF) and Physicians Resources, interviewed Dr. Suneel Chilukuri (a dermatologic surgeon with Refresh Dermatology in Houston)…
Next Steps in Derm and the Journal of Drugs in Dermatology, in partnership with the Dermatology Education Foundation (DEF) and Physicians Resources, interviewed Dr. Hilary Baldwin, a board-certified dermatologist and medical director of the…
Allure featured a JDD study in its article about inclusivity in cosmetic procedures. The study, “Understanding the Female African American Facial Aesthetic Patient,” by Andrew Alexis, MD, MPH, and colleagues,…
j iTunes TuneIn Spotify Dr. Nanette Silverberg & Adam Friedman, MD, FAAD There are a number of dermatologic conditions that in part result from our daily behaviors - for some reason…
Dermatology Times and Dermatology Advisor each featured a February JDD study about topical clascoterone for facial acne vulgaris. The study, “Efficacy and Safety of 1% Clascoterone Cream in Patients Aged…
By Allison Sit The FDA is implementing changes to the iPLEDGE program that will alleviate administrative burdens for dermatologists. The changes come after two years of advocacy by the American…
Free Full Text - A popular review article from the JDDonline Archives on tretinoin use over 40 years. Luciana Nofal 40 Years of Topical Tretinoin Use in Review From the…
By Allison Sit The Food and Drug Administration has approved Restylane Contour for cheek augmentation and correction of midface contour deficiencies in adults older than 21. Approval of the new…
By Allison Sit The Journal of Drugs in Dermatology is featured in the June issue of Dermatology Times. The publication included a 2020 JDD study in its article, “COVID-19 Increases…